Evidence for epistatic interactions in antiepileptic drug resistance

Journal of Human Genetics

Volumn 56, Issue 1, 2011, Pages 71-76

  Kim, Myeong Kyu ^a   Moore, Jason H ^b   Kim, Jong Ki ^a   Cho, Ki Hyun ^a   Cho, Yong Won ^c   Kim, Yo Sik ^d   Lee, Min Cheol ^a   Kim, Young Ok ^a   Shin, Min Ho ^a  

^a Chonnam National University Medical School   (South Korea)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c Dongsan Medical Center   (South Korea)

^d Wonkwang University School of Medicine   (South Korea)

Author keywords

drug resistance; epilepsy; epistasis; pharmacogenetics

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ANALYTIC METHOD; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; EPILEPSY; FEMALE; GENE INTERACTION; GENE POOL; GENETIC EPISTASIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIFACTOR DIMENSIONALITY REDUCTION; PHARMACOGENETICS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS;

ADOLESCENT; ADULT; ANTICONVULSANTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; EPILEPSY; EPISTASIS, GENETIC; FEMALE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; VALIDATION STUDIES AS TOPIC; YOUNG ADULT;

EID: 79251621709     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.151     Document Type: Article

References (31)

1. Kwan, P. & Brodie, M. J. Early identification of refractory epilepsy. N. Engl. J. Med. 342, 314-319 (2000).
2. Regesta, G. & Tanganelli, P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res. 34, 109-122 (1999).
3. Kwan, P. & Brodie, M. J. Refractory epilepsy: a progressive, intractable but preventable condition? Seizure 11, 77-84 (2002).
4. Evans, W. E. & Relling, M. V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286, 487-491 (1999).
5. McLeod, H. L. & Evans, W. E. Pharmacogenomics: unlocking the human genome for better drug therapy. Annu. Rev. Pharmacol. Toxicol. 41, 101-121 (2001).
6. Gibson, G. Epistasis and pleiotropy as natural properties of transcriptional regulation. Theor. Popul. Biol. 49, 58-89 (1996).
7. Ritchie, M. D., Hahn, L. W., Roodi, N., Bailey, L. R., Dupont, W. D., Parl, F. F. et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogenmetabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 69, 138-147 (2001).
8. Williams, S. M., Ritchie, M. D., Phillips, J. A. III., Dawson, E., Prince, M., Dzhura, E. et al. Multilocus analysis of hypertension: a hierarchical approach. Hum. Hered. 57, 28-38 (2004).
9. Siddiqui, A., Kerb, R., Weale, M. E., Brinkmann, U., Smith, A., Goldstein, D. B. et al. Association of multidrug resistance in epilepsy with a polymorphism in the drugtransporter gene ABCB1. N. Engl. J. Med. 348, 1442-1448 (2003).
10. Depondt, C. The potential of pharmacogenetics in the treatment of epilepsy. Eur. J. Paediatr. Neurol. 10, 57-65 (2006).
11. Kim, Y. O., Kim, M. K., Woo, Y. J., Lee, M. C., Kim, J. H., Park, K. W. et al. Single nucleotide polymorphisms in the multidrug resistance 1 gene in Korean epileptics. Seizure 15, 67-72 (2006).
12. Shahwan, A., Murphy, K., Doherty, C., Cavalleri, G. L., Muckian, C., Dicker, P. et al. The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population. Epilepsy Res. 73, 192-198 (2007).
13. Templeton, A. R. in Epistasis and The Evolutionary Process (eds. Wade, M., Brodie, B. III & Wolf, J.) 41-57 (Oxford Univ. Press, Oxford, 2000).
14. Glazier, A. M., Nadeau, J. H. & Aitman, T. J. Finding genes that underlie complex traits. Science 298, 2345-2349 (2002).
15. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30, 389-399 (1989).
16. Loscher, W. & Potschka, H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J. Pharmacol. Exp. Ther. 301, 7-14 (2002).
17. Lazarowski, A., Czornyj, L., Lubienieki, F., Girardi, E., Vazquez, S. & DGiano, C. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy. Epilepsia 48 (Suppl 5), 140-149 (2007).
18. McNamara, J. O. in Goodmann & Gilmans The Pharmacological Basis of Therapeutics (eds. Hardman, J.G., Limbird, L.E., & Gilman, A.G.) 521-547 (McGraw-Hill, New York, 2001).
19. Gardiner, M. Genetics of idiopathic generalized epilepsies. Epilepsia 46 (Suppl 9), 15-20 (2005).
20. Meldrum, B. S. & Rogawski, M. A. Molecular targets for antiepileptic drug development. Neurotherapeutics 4, 18-61 (2007).
21. Kim, M. K., Nam, T. S., Choi, K. H., Jang, S. Y., Kim, Y. O. & Lee, M. C. Usefulness of direct sequencing of pooled DNA for SNP identification and allele-frequency determination compatible with a common disease/common variant hypothesis. Genet. Mol. Res. 9, 772-779 (2010).
22. Moore, J. H., Gilbert, J. C., Tsai, C. T., Chiang, F. T., Holden, W., Barney, N. et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J. Theor. Biol. 241, 252-261 (2006).
23. Moore, J. H., White, B. C. in Lecture Notes in Computer Science (eds. Rajapakse, J. C. et al.) 166-175 (Springer, New York, 2007).
24. Velez, D. R., White, B. C., Motsinger, A. A., Bush, W. S., Ritchie, M. D., Williams, S. M. et al. A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Genet. Epidemiol. 31, 306-315 (2007).
25. Szoeke, C. E., Newton, M ., Wood, J. M., Goldstein, D., Berkovic, S. F., Obrien, T. J. et al. Update on pharmacogenetics in epilepsy: a brief review. Lancet Neurol. 5, 189-196 (2006).
26. Pharoah, P.D., Dunning, A.M., Ponder, B.A. & Easton, D.F. Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer 4, 850-860 (2004).
27. Thornton-Wells, T. A., Moore, J. H. & Haines, J. L. Genetics, statistics and human disease: analytical retooling for complexity. Trends Genet. 20, 640-647 (2004).
28. Cordell, H. J. Epistasis: what it means, what it doesnt mean, and statistical methods to detect it in humans. Hum. Mol. Genet. 11, 2463-2468 (2002).
29. Moore, J. H. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum. Hered. 56, 73-82 (2003).
30. Beck, H. Plasticity of antiepileptic drug targets. Epilepsia 48 (Suppl 1), 14-18 (2007).
31. Jang, S. Y., Kim, M. K., Lee, K. R., Park, M. S., Kim, B. C., Cho, K. H. et al. Gene-togene interaction between sodium channel-related genes in determining the risk of antiepileptic drug resistance. J. Korean. Med. Sci. 24, 62-68 (2009).